# EDGAR Filing Document

**Accession Number:** 0001563325
**File Stem:** 0001104659-25-111322
**Filing Date:** 2025-11
**Character Count:** 23561
**Document Hash:** 7349fa9d313c00e00f658cb4397f3595
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-111322.hdr.sgml**: 20251113

**ACCESSION NUMBER**: 0001104659-25-111322

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20251113

**DATE AS OF CHANGE**: 20251113

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Picard Medical, Inc.
- **CENTRAL INDEX KEY:** 0002030617
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-95330
- **FILM NUMBER:** 251478673

**BUSINESS ADDRESS:**
- **STREET 1:** 1992 E. SILVERLAKE RD.
- **CITY:** TUCSON
- **STATE:** AZ
- **ZIP:** 85713
- **BUSINESS PHONE:** 520-308-0796

**MAIL ADDRESS:**
- **STREET 1:** 1992 E. SILVERLAKE RD.
- **CITY:** TUCSON
- **STATE:** AZ
- **ZIP:** 85713
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VERSA CAPITAL FUND III, L.P.
- **CENTRAL INDEX KEY:** 0001563325

**ORGANIZATION NAME:**
- **EIN:** 460572907
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 130 N. 18TH STREET
- **STREET 2:** SUITE 315
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19103
- **BUSINESS PHONE:** 215-609-3406

**MAIL ADDRESS:**
- **STREET 1:** 130 N. 18TH STREET
- **STREET 2:** SUITE 315
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19103

## Exhibit 99.1

**<u>Exhibit 1</u>**

**<u>JOINT FILING AGREEMENT</u>**

This JOINT FILING AGREEMENT, dated as of October 7, 2025, is by and among Sindex SSI Lending, LLC, a Delaware limited liability company, Versa Capital Fund III, L.P., a Delaware limited partnership, Versa FGP-III, L.P., a Delaware limited partnership, Versa UGP-III, LLC, a Delaware limited liability company, Versa Capital Group, LLC, a Delaware limited liability company, and Gregory L. Segall, an individual (collectively, the "Reporting Persons").

WHEREAS, pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Reporting Persons desire to satisfy any filing obligation under Section 13(d) of the Exchange Act by a single joint filing;

NOW, THEREFORE, in consideration of the premises and the mutual covenants herein contained, the Reporting Persons hereby agree and represent as follows:

&nbsp;&nbsp;&nbsp;&nbsp;1. Schedule 13G with respect to the common stock, $0.0001 par value per share, of Picard Medical, Inc. (to which this Joint Filing Agreement is an exhibit) is filed on behalf of each of the Reporting Persons.

2. Each of the Reporting Persons is responsible for the timely filing of Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such Person contained therein, provided that each such Person is not responsible for the completeness or accuracy of the information concerning any of the other Reporting Persons, unless such Person knows or has reason to believe that such information is inaccurate.

IN WITNESS WHEREOF, the undersigned have caused this Joint Filing Agreement to be duly executed and delivered as of the date first above written.

Date: November 13, 2025 <br>

---

| |
|:---|
| /s/ Randall Schultz |
| Randall Schultz, as Attorney-in-Fact for: |
| Sindex SSI Lending, LLC (1) |
| Versa Capital Fund III, L.P. (1) |
| Versa FGP-III, L.P. (1) |
| Versa UGP-III, LLC (1) |
| Versa Capital Group, LLC (1) |
| Gregory L. Segall (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) A Power of Attorney authorizing Randall Schultz to act on behalf of this entity or individual is filed as Exhibit 2 to the Schedule 13G. |

---

## Exhibit 99.2

**<u>Exhibit 2</u>**

**<u>Power of Attorney</u>**

KNOW ALL PERSONS BY THESE PRESENTS, that each of Sindex SSI Lending, LLC, a Delaware limited liability company, Versa Capital Fund III, L.P., a Delaware limited partnership, Versa FGP-III, L.P., a Delaware limited partnership, Versa UGP-III, LLC, a Delaware limited liability company, Versa Capital Group, LLC, a Delaware limited liability company, and Gregory L. Segall, an individual (each a "Grantor") has made, constituted and appointed, and by these presents does make, constitute and appoint, Randall Schultz ("Attorney"), the true and lawful agent and attorney-in-fact, with full power of substitution and resubstitution, of the Grantor, for and in Grantor's name, place and stead, in any and all capacities, to do all or any of the following acts, matters and things:

&nbsp;&nbsp;&nbsp;&nbsp;1. To sign on behalf of the Grantor statements on Schedule 13D or 13G or Forms 3, 4 and 5, or amendments thereto pursuant to Section 13(d) or Section 16 under the Securities Exchange Act of 1934.

2. To do all such other acts and things as, in such Attorney's discretion, he or she deems appropriate or desirable for the purpose of filing such statements on Schedule 13D or 13G or Forms 3, 4 and 5, or amendments thereto.

3. To appoint in writing one or more substitutes who shall have the power to act on behalf of the Grantor as if that substitute or those substitutes shall have been originally appointed Attorney(s) by this Power of Attorney and/or to revoke any such appointment at any time without assigning any reason therefor.

IN WITNESS WHEREOF, Grantor duly assents to this Power of Attorney by his, her or its signature as of the date below.

Date: November 13, 2025 <br>

---

| |
|:---|
| /s/ Randall Schultz |
| Randall Schultz, Authorized Agent for Sindex SSI Lending, LLC |
| /s/ Randall Schultz |
| Randall Schultz, Authorized Agent for Versa Capital Fund III, L.P. |
| /s/ Randall Schultz |
| Randall Schultz, Authorized Agent for Versa FGP-III, L.P. |
| /s/ Randall Schultz |
| Randall Schultz, Authorized Agent for Versa UGP-III, LLC |
| /s/ Randall Schultz |
| Randall Schultz, Authorized Agent for Versa Capital Group, LLC |
| /s/ Gregory L. Segall |
| Gregory L. Segall, an individual |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** Picard Medical, Inc.

**Title of Class of Securities:** Common Stock, $0.0001 par value per share

**CUSIP Number:** 740459102

**Date of Event Which Requires Filing of this Statement:** 08/11/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Sindex SSI Lending, LLC | Names of Reporting Persons<br>Sindex SSI Lending, LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>10.8% | Percent of Class Represented by Amount in Row (9)<br>10.8% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** This percentage is calculated based on 73,701,176 shares of Common Stock of the Issuer issued and outstanding as of September 16, 2025.

---

| 1. | Names of Reporting Persons<br>Versa Capital Fund III, L.P. | Names of Reporting Persons<br>Versa Capital Fund III, L.P. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>10.8% | Percent of Class Represented by Amount in Row (9)<br>10.8% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** This percentage is calculated based on 73,701,176 shares of Common Stock of the Issuer issued and outstanding as of September 16, 2025.

---

| 1. | Names of Reporting Persons<br>Versa FGP-III, L.P. | Names of Reporting Persons<br>Versa FGP-III, L.P. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>10.8% | Percent of Class Represented by Amount in Row (9)<br>10.8% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** This percentage is calculated based on 73,701,176 shares of Common Stock of the Issuer issued and outstanding as of September 16, 2025.

---

| 1. | Names of Reporting Persons<br>Versa UGP-III, LLC | Names of Reporting Persons<br>Versa UGP-III, LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>10.8% | Percent of Class Represented by Amount in Row (9)<br>10.8% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** This percentage is calculated based on 73,701,176 shares of Common Stock of the Issuer issued and outstanding as of September 16, 2025.

---

| 1. | Names of Reporting Persons<br>Versa Capital Group, LLC | Names of Reporting Persons<br>Versa Capital Group, LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>10.8% | Percent of Class Represented by Amount in Row (9)<br>10.8% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** This percentage is calculated based on 73,701,176 shares of Common Stock of the Issuer issued and outstanding as of September 16, 2025.

---

| 1. | Names of Reporting Persons<br>Gregory L. Segall | Names of Reporting Persons<br>Gregory L. Segall |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>7943585.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>7943585.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>10.8% | Percent of Class Represented by Amount in Row (9)<br>10.8% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

**Comment for Type of Reporting Person:** This percentage is calculated based on 73,701,176 shares of Common Stock of the Issuer issued and outstanding as of September 16, 2025.

---

**Item 1(a). Name of Issuer:**
Picard Medical, Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
1992 E Silverlake, Tucson, AZ 85713

**Item 2(a). Name of Person Filing:**
(1) Sindex SSI Lending, LLC, a Delaware limited liability company ("Sindex")
(2) Versa Capital Fund III, L.P., a Delaware limited partnership ("CF III")
(3) Versa FGP-III, L.P., a Delaware limited partnership ("FGP-III")
(4) Versa UGP-III, LLC, a Delaware limited liability company ("UGP-III")
(5) Versa Capital Group, LLC, a Delaware limited liability company ("Versa")
(6) Gregory L. Segall, an individual ("Mr. Segall" and, together with Sindex, CF III, FGP III, UGP III, and Versa, the "Reporting Persons")

**Item 2(b). Address of Principal Business Office:**
c/o Versa Capital Management, LLC
130 N. 18th Street
Suite 315
Philadelphia, PA 19103

**Item 2(c). Citizenship:**
Mr. Segall is a citizen of the United States. The other Reporting Persons were formed under the laws of the State of Delaware.

**Item 2(d). Title of Class of Securities:**
Common Stock, $0.0001 par value per share

**Item 2(e). CUSIP Number:**
740459102

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

Sindex SSI Lending, LLC: 7,943,585 shares of Common Stock
Versa Capital Fund III, L.P.: 7,943,585 shares of Common Stock
Versa FGP-III, L.P.: 7,943,585 shares of Common Stock
Versa UGP-III, LLC: 7,943,585 shares of Common Stock
Versa Capital Group, LLC: 7,943,585 shares of Common Stock
Gregory L. Segall: 7,943,585 shares of Common Stock

**(b) Percent of class:**

Sindex SSI Lending, LLC: 10.8%
Versa Capital Fund III, L.P.: 10.8%
Versa FGP-III, L.P.: 10.8%
Versa UGP-III, LLC: 10.8%
Versa Capital Group, LLC: 10.8%
Gregory L. Segall: 10.8%

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

Sindex SSI Lending, LLC: 7,943,585
Versa Capital Fund III, L.P.: 7,943,585
Versa FGP-III, L.P.: 7,943,585
Versa UGP-III, LLC: 7,943,585
Versa Capital Group, LLC: 7,943,585
Gregory L. Segall: 7,943,585

**(ii) Shared power to vote or to direct the vote:**

Sindex SSI Lending, LLC: 0
Versa Capital Fund III, L.P.: 0
Versa FGP-III, L.P.: 0
Versa UGP-III, LLC: 0
Versa Capital Group, LLC: 0
Gregory L. Segall: 0

**(iii) Sole power to dispose or to direct the disposition of:**

Sindex SSI Lending, LLC: 7,943,585
Versa Capital Fund III, L.P.: 7,943,585
Versa FGP-III, L.P.: 7,943,585
Versa UGP-III, LLC: 7,943,585
Versa Capital Group, LLC: 7,943,585
Gregory L. Segall: 7,943,585

**(iv) Shared power to dispose or to direct the disposition of:**

Sindex SSI Lending, LLC: 0
Versa Capital Fund III, L.P.: 0
Versa FGP-III, L.P.: 0
Versa UGP-III, LLC: 0
Versa Capital Group, LLC: 0
Gregory L. Segall: 0

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Sindex SSI Lending, LLC**

**Date:** 11/13/2025

**By:** /s/ Randall Schultz

**Name & Title:** Randall Schultz, as Attorney-in-Fact for: Sindex SSI Lending, LLC (1)

**Versa Capital Fund III, L.P.**

**Date:** 11/13/2025

**By:** /s/ Randall Schultz

**Name & Title:** Randall Schultz, as Attorney-in-Fact for: Versa Capital Fund III, L.P. (1)

**Versa FGP-III, L.P.**

**Date:** 11/13/2025

**By:** /s/ Randall Schultz

**Name & Title:** Randall Schultz, as Attorney-in-Fact for: Versa FGP-III, L.P. (1)

**Versa UGP-III, LLC**

**Date:** 11/13/2025

**By:** /s/ Randall Schultz

**Name & Title:** Randall Schultz, as Attorney-in-Fact for: Versa UGP-III, LLC (1)

**Versa Capital Group, LLC**

**Date:** 11/13/2025

**By:** /s/ Randall Schultz

**Name & Title:** Randall Schultz, as Attorney-in-Fact for: Versa Capital Group, LLC (1)

**Gregory L. Segall**

**Date:** 11/13/2025

**By:** /s/ Randall Schultz

**Name & Title:** Randall Schultz, as Attorney-in-Fact for: Gregory L. Segall (1)